<Supplemental Information> Regarding the Content of “Business Strategies and Progress by Segment” (p. 33-40)

With the establishment of the Human Life Solutions Sector, we have reorganized business segments in FY2022.
The “Summary of Overall Business” on p. 33-34 is categorized according to the four segments in FY2021: “Industrial Tape,” “Optronics,” “Life Science,” and “Others.” However, on p. 35-40 which describes “Our Goals for 2030” and “Mid- and Long-Term Strategies,” the “Human Life”* segment, newly established in FY2022, is listed along with “Industrial Tape” and “Optronics.”
*In addition to the conventional contributions of medicines, the “Human Life” segment will accelerate the development of products that contribute to coexistence with the global environment and people's lives and livelihoods.